Listar Producción Científica por autor "de0bc1e2-cdb8-4085-84bd-7fd636b4ced0"
Mostrando ítems 1-2 de 2
-
Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas
Guil-Luna, Silvia; Sánchez Céspedes, Raquel; Millán, Yolanda; De Andrés, Francisco Javier; Rollón, Eva; Domingo, Victor; Guscetti, Franco; Martín de las Mulas González-Albo, Juana (Wiley, 2011)Progesterone receptor (PR) antagonist aglepristone (RU534) has been used successfully for pregnancy termination and therapy of pyometra, vaginal tumors, and mammary hyperplasia in bitches and queens. All of these conditions ... -
Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas
Guil-Luna, Silvia; Millán, Yolanda; De Andrés, Francisco Javier; Rollón, Eva; Domingo, Victor; García-Macías, Javier; Martín de las Mulas González-Albo, Juana (Wiley, 2017)Neoadjuvant treatment of canine mammary carcinomas with the progesterone receptor (PR) antagonist aglepristone has a PR expression-related inhibiting effect on proliferation index (PI). The aim of this study was to evaluate ...